Constitutive_JJ
dephosphorylation_NN
and_CC
activation_NN
of_IN
a_DT
member_NN
of_IN
the_DT
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
,_,
NF-AT1_NN
,_,
in_IN
Tax-expressing_JJ
and_CC
type_NN
I_NN
human_JJ
T-cell_NN
leukemia_NN
virus-infected_JJ
human_JJ
T_NN
cells_NNS
._.

The_DT
tax_NN
gene_NN
product_NN
of_IN
the_DT
type_NN
I_CD
human_JJ
T-cell_NN
leukemia_NN
virus_NN
-LRB-_-LRB-
HTLV-I_NN
-RRB-_-RRB-
transactivates_VBZ
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
gene_NN
through_IN
activation_NN
of_IN
an_DT
enhancer_NN
termed_VBN
CD28_NN
responsive_JJ
element_NN
-LRB-_-LRB-
CD28RE_NN
-RRB-_-RRB-
._.

Tax_NN
activation_NN
of_IN
the_DT
CD28RE_NN
is_VBZ
partially_RB
mediated_VBN
by_IN
a_DT
member_NN
of_IN
the_DT
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
,_,
NF-AT1_NN
._.

We_PRP
have_VBP
previously_RB
shown_VBN
that_IN
NF-AT1_NN
is_VBZ
constitutively_RB
active_JJ
in_IN
Jurkat_NN
T_NN
cells_NNS
stably_RB
transfected_VBN
with_IN
the_DT
Tax_NN
cDNA_NN
,_,
although_IN
the_DT
underlying_JJ
molecular_JJ
mechanism_NN
and_CC
physiological_JJ
relevance_NN
of_IN
this_DT
finding_NN
remain_VBP
unclear_JJ
._.

In_IN
this_DT
report_NN
,_,
we_PRP
demonstrate_VBP
that_IN
the_DT
active_JJ
form_NN
of_IN
NF-AT1_NN
is_VBZ
also_RB
present_JJ
in_IN
the_DT
nuclei_NNS
of_IN
HTLV-I-transformed_JJ
T_NN
cells_NNS
that_WDT
express_VBP
the_DT
Tax_NN
protein_NN
._.

Interestingly_RB
,_,
the_DT
constitutive_JJ
activation_NN
of_IN
NF-AT1_NN
in_IN
these_DT
T_NN
cells_NNS
is_VBZ
associated_VBN
with_IN
its_PRP$
dephosphorylation_NN
._.

Furthermore_RB
,_,
the_DT
dephosphorylated_VBN
NF-AT1_NN
can_MD
be_VB
rapidly_RB
rephosphorylated_VBN
when_WRB
the_DT
cells_NNS
are_VBP
incubated_VBN
with_IN
cyclosporin_NN
A_NN
,_,
an_DT
immunosuppressant_NN
inhibiting_VBG
the_DT
serine\/threonine_NN
phosphatase_NN
calcineurin_NN
._.

These_DT
results_NNS
suggest_VBP
that_IN
activation_NN
of_IN
NF-AT1_NN
in_IN
Tax-expressing_JJ
and_CC
HTLV-I-transformed_JJ
T_NN
cells_NNS
results_VBZ
from_IN
its_PRP$
dephosphorylation_NN
,_,
which_WDT
in_IN
turn_NN
may_MD
be_VB
due_JJ
to_TO
deregulation_NN
of_IN
calcineurin_NN

